Patricia Braga

Patricia Braga

Auto-generated profile, based on publicly available information

Patricia Braga

Instituto de Neurología, Hospital de Clínicas "Dr. Manuel Quintela", Facultad de Medicina, Universidad de la República, Address: Av. Italia sn, CP 11600. Montevideo, Uruguay

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Epilepsia
Verified
Journal Article
Closed access
PDF file
CKChurl-Su Kwon
Churl-Su Kwon
AJAnn Jacoby
Ann Jacoby
AAAmza Ali
Amza Ali
JAJoan Austin
Joan Austin
GBGretchen L. Birbeck
Gretchen L. Birbeck
NJNathalie Jette
Nathalie Jette

1 May 2009 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
ASAlejandro Scaramelli
Alejandro Scaramelli
PBPatricia Braga
Patricia Braga
AAAndrea Avellanal
Andrea Avellanal
ABAlicia Bogacz
Alicia Bogacz
CCClaudia Camejo
Claudia Camejo
BABeatriz Arciere
Beatriz Arciere

5 January 2022 in Epilepsia
Verified
Journal Article
Closed access
PDF file
JAJoan K. Austin
Joan K. Austin
GBGretchen Birbeck
Gretchen Birbeck
KPKaren Parko
Karen Parko
CKChurl-Su Kwon
Churl-Su Kwon
PFPaula T. Fernandes
Paula T. Fernandes
NJNathalie Jette
Nathalie Jette

29 March 2012 in Epilepsia
Verified
Journal Article
Closed access
PDF file
SBSándor Beniczky
Sándor Beniczky
MGMirian Salvadori Bittar Guaranha
Mirian Salvadori Bittar Guaranha
ICIsa Conradsen
Isa Conradsen
MSMamta Bhushan Singh
Mamta Bhushan Singh
VRVeronika Rutar
Veronika Rutar
PWPeter Wolf
Peter Wolf

1 October 2018 in Epileptic Disorders
Verified
Journal Article
Closed access
JCJaime Carrizosa
Jaime Carrizosa
PBPatricia Braga
Patricia Braga
MAMarly Albuquerque
Marly Albuquerque
ABAlicia Bogacz
Alicia Bogacz
JBJorge Burneo
Jorge Burneo
EYElza M. Yacubian
Elza M. Yacubian
Aims. A lack of neurologists in Latin America forces primary health care providers to manage epilepsy. With the main goal of improving diagnostic and therapeutic management of patients with epilepsy through training of physicians in the primary health care level, the International League Against Epilepsy Education Commission (2013–2017) created a low‐cost, regional, virtual course.Methods. The course, set‐up in Moodle platform, was structured in eight modules, each lasting for a week. Teaching was based on written didactic material, videos, and interactive discussions, both in Spanish and Portuguese. Topics included epidemiology, diagnosis, classification, treatment, prognosis, social issues, and epilepsy policies. Each course was limited to 50 participants and priority was given to general practitioners. Certification was given to those approving the final examination.Results. Since 2015, five courses have been developed, involving 143 participants from 17 countries and 21 tutors. Of the participants, 61% worked in primary health care services. A total of 129 participants (90%) completed the course, and 110 submitted the final examination with an approval rate of 95%. From 85 participants completing the course evaluation, 98% would recommend the course to other colleagues, and 99% showed interest in taking other similar courses. High self‐confidence for the management of patients with epilepsy increased from 21% at baseline to 73% after the course.Conclusions. The online course on epilepsy for primary care physicians in Latin America was shown to be a cost‐effective course, with good retention and excellent approval rates. Our current challenges include periodic updating, complete self‐sustainability, and exploring different strategies to reach our target audience more effectively.

27 January 2024 in Epilepsia
Verified
Journal Article
Open access
Professor EMILIO PERUCCA PERUCCAProfessor EMILIO PERUCCA PERUCCA
Professor EMILIO PERUCCA PERUCCA
JFJacqueline A. French
Jacqueline A. French
GAGhaieb Aljandeel
Ghaieb Aljandeel
SBSimona Balestrini
Simona Balestrini
PBPatricia Braga
Patricia Braga
JKJaideep Kapur
Jaideep Kapur
A variety of terms, such as “antiepileptic,” “anticonvulsant,” and “antiseizure” have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English‐language terminology applicable to pharmacological agents currently approved for treating seizure disorders. There was consensus that these medications should be collectively named “antiseizure medications”. This term accurately reflects their primarily symptomatic effect against seizures and reduces the possibility of health care practitioners, patients, or caregivers having undue expectations or an incorrect understanding of the real action of these medications. The term “antiseizure” to describe these agents does not exclude the possibility of beneficial effects on the course of the disease and comorbidities that result from the downstream effects of seizures, whenever these beneficial effects can be explained solely by the suppression of seizure activity. It is acknowledged that other treatments, mostly under development, can exert direct favorable actions on the underlying disease or its progression, by having “antiepileptogenic” or “disease‐modifying” effects. A more‐refined terminology to describe precisely these actions needs to be developed.